TB-500 for Dogs

TB-500 is a synthetic peptide built from a fragment of thymosin beta-4, a small protein your dog's own body already produces. Thymosin beta-4 is involved in how cells move around the body, how they communicate with each other, and how tissue organizes itself during repair. TB-500 was developed to mimic a portion of that natural protein's activity.

It is not a drug approved for veterinary use, and it should not be confused with a finished, government-reviewed medication. In our program, TB-500 is treated the same way we treat every other compound: as a tool that may or may not be appropriate for a specific dog, decided by our supervising veterinarian rather than by a general dosing chart.

Most conversations about TB-500 start with a specific, practical concern rather than curiosity about peptide science. The situations that come up most often include:

• Soft-tissue injuries — strains, sprains and general soft-tissue trauma that are slow to settle down on their own.
• Tendon and ligament injuries — including the kind of wear-and-tear problems seen in active or working dogs.
• Post-surgical recovery — owners looking to support their dog's body through the weeks after an orthopedic or soft-tissue procedure.
• Mobility in older dogs — where general stiffness and slower recovery from everyday activity have become noticeable.
• Wound healing — chronic or slow-to-close wounds that have not responded well to standard care.

Bringing any of these situations to our program does not mean TB-500 will be recommended. It means our supervising veterinarian will look at the whole picture — including whether the underlying issue has actually been diagnosed — before deciding whether a peptide protocol belongs in the plan at all.

TB-500 is not FDA-approved for use in animals, and the published evidence specific to dogs is limited. That does not automatically mean it is unsafe, but it does mean that safety in this program rests almost entirely on veterinary review and ongoing monitoring rather than on a general guarantee.

Because TB-500 relates to signaling involved in cell movement and tissue growth, our supervising veterinarian pays particular attention to any dog with a current or past history of cancer, and to dogs with other complicating conditions. In those cases the veterinarian may decide that TB-500 is not appropriate for that individual animal, and that decision is treated as a normal, expected outcome of the review — not an exception to it.

The same caution applies to pregnant or nursing dogs, dogs on multiple medications, and any dog whose symptoms have not yet been properly diagnosed. If your dog fits into one of those categories, expect our veterinarian to ask more questions before discussing TB-500 at all.

There is no single TB-500 dosage for dogs that applies across the board. The right amount depends on your dog's body weight, the reason TB-500 is being considered, your dog's overall health, and anything else your dog is currently taking. For that reason, we do not publish specific dosing figures — the table below shows the weight bands our supervising veterinarian works from, with the actual protocol filled in only after your dog has been reviewed and a plan has been approved.

Want a rough sense of where your dog falls before you talk to us? Enter a weight below — this tool will not generate a dose until our veterinarian has approved one for your animal.

TB-500 and BPC-157 for dogs are the two peptides owners bring up most, and it is common to wonder whether one is simply better than the other. In practice, owners and clinicians tend to think of them as addressing overlapping but distinct pieces of recovery: BPC-157 is often discussed in the context of general gut and soft-tissue support, while TB-500 is often discussed in the context of broader tissue repair and cell movement. Some protocols our supervising veterinarian designs use one or the other; some use both together.

There is no owner-facing formula for deciding this. Whether TB-500, BPC-157, or a combination is right for your dog is a veterinary decision that depends on the specific injury, its location, how long it has been present, and your dog's broader health picture. That decision is made during the veterinary review, not before it.

Some peptide protocols are structured in two stages: an initial period, sometimes called a loading phase, followed by a lighter maintenance phase once the desired response has started to show. The general idea is to establish a stronger initial effect and then taper to the lowest amount that keeps supporting recovery.

We are not going to describe a specific loading schedule here, because whether your dog's plan uses this structure at all, how long each phase lasts, and how the protocol changes between them are all decisions made by our supervising veterinarian based on how your dog is actually responding — not a fixed timeline applied to every dog automatically.

As with any protocol used outside the boundaries of large-scale, FDA-reviewed animal studies, it is important to watch your dog closely and report anything unusual. Things worth flagging to our supervising veterinarian include swelling, redness or discomfort at an injection site, unusual lethargy or changes in energy, a drop in appetite, vomiting or diarrhea, or any behavior that is out of character for your dog.

None of these signs necessarily mean TB-500 is the cause, but they are exactly the kind of information our veterinarian needs in order to decide whether to continue, adjust, or pause the plan.

If you think TB-500 might be relevant for your dog's recovery, the next step is not to guess at a dose — it is to bring your dog's history to our veterinary team. Tell us about the injury or condition, how long it has been going on, your dog's weight and age, and any medications or supplements your dog is currently on. From there, our supervising veterinarian will review the case and let you know whether TB-500, BPC-157 for dogs, a combination, or a different approach altogether makes the most sense. You can also read more broadly about peptides for dogs or explore peptide therapy for dogs for a wider view of how these protocols are used in our program.